BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29497781)

  • 1. From gene networks to drugs: systems pharmacology approaches for AUD.
    Ferguson LB; Harris RA; Mayfield RD
    Psychopharmacology (Berl); 2018 Jun; 235(6):1635-1662. PubMed ID: 29497781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Analysis of Genetic, Genomic, and Phenotypic Data for Ethanol Behaviors: A Network-Based Pipeline for Identifying Mechanisms and Potential Drug Targets.
    Bogenpohl JW; Mignogna KM; Smith ML; Miles MF
    Methods Mol Biol; 2017; 1488():531-549. PubMed ID: 27933543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Expression Profiles Drive Discovery of Novel Compounds that Reduce Binge Drinking in Mice.
    Ferguson LB; Ozburn AR; Ponomarev I; Metten P; Reilly M; Crabbe JC; Harris RA; Mayfield RD
    Neuropsychopharmacology; 2018 May; 43(6):1257-1266. PubMed ID: 29251283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging genetic data to investigate molecular targets and drug repurposing candidates for treating alcohol use disorder and hepatotoxicity.
    Gray JC; Murphy M; Leggio L
    Drug Alcohol Depend; 2020 Sep; 214():108155. PubMed ID: 32652377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconciling multiple connectivity scores for drug repurposing.
    Samart K; Tuyishime P; Krishnan A; Ravi J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
    Zador Z; King AT; Geifman N
    PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pathway-Based Genomic Approach to Identify Medications: Application to Alcohol Use Disorder.
    Ferguson LB; Patil S; Moskowitz BA; Ponomarev I; Harris RA; Mayfield RD; Messing RO
    Brain Sci; 2019 Dec; 9(12):. PubMed ID: 31888299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging pharmacotherapies for alcohol use disorder.
    Mason BJ
    Neuropharmacology; 2017 Aug; 122():244-253. PubMed ID: 28454983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
    Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
    Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the new genomics to alcohol dependence.
    Farris SP; Pietrzykowski AZ; Miles MF; O'Brien MA; Sanna PP; Zakhari S; Mayfield RD; Harris RA
    Alcohol; 2015 Dec; 49(8):825-36. PubMed ID: 25896098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma.
    Chung FH; Chiang YR; Tseng AL; Sung YC; Lu J; Huang MC; Ma N; Lee HC
    PLoS One; 2014; 9(1):e86299. PubMed ID: 24475102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing in silico drug discovery: simulation of connected differential expression signatures and applications to benchmarking.
    Gonzalez Gomez C; Rosa-Calatrava M; Fouret J
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38935068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug addiction co-morbidity with alcohol: Neurobiological insights.
    McGinn MA; Pantazis CB; Tunstall BJ; Marchette RCN; Carlson ER; Said N; Koob GF; Vendruscolo LF
    Int Rev Neurobiol; 2021; 157():409-472. PubMed ID: 33648675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.
    Koob GF; Colrain IM
    Neuropsychopharmacology; 2020 Jan; 45(1):141-165. PubMed ID: 31234199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrative Transcriptomic Analysis of Systemic Juvenile Idiopathic Arthritis for Identifying Potential Genetic Markers and Drug Candidates.
    Kim D; Song J; Lee S; Jung J; Jang W
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.